Viewing Study NCT01179295


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-03 @ 5:44 PM
Study NCT ID: NCT01179295
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2010-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Japanese BAY86-9766 Monotherapy Phase I Study
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEK inhibitor View
None BAY86-9766 View
None RDEA 119 View
None Solid tumor View